tiprankstipranks
Advertisement

AVDE - ETF AI Analysis

Compare

Top Page

AVDE

Avantis International Equity ETF (AVDE)

Rating:65Neutral
Price Target:
AVDE, the Avantis International Equity ETF, has a solid overall rating, mainly supported by strong global leaders like ASML, Toyota, Novartis, and AstraZeneca, which bring robust financial performance, innovation, and positive growth outlooks to the portfolio. Energy names such as Shell and TotalEnergies also add stability with solid profitability and supportive technical trends, though some holdings like BP and Safran face profitability, leverage, or valuation concerns that slightly weigh on the fund’s rating. The main risk factor is its meaningful exposure to large international energy and pharmaceutical companies, which can be sensitive to regulation, commodity prices, and sector-specific challenges.
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, which helps reduce the impact if any single market struggles.
Balanced Sector Mix
Holdings are spread across financials, industrials, materials, energy, technology, and other sectors, lowering the risk of being tied to one part of the economy.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating recent strength in its portfolio.
Negative Factors
Exposure to Underperforming Top Holdings
A few of the largest positions, such as Roche, Toyota, and Safran, have been weak this year, which can drag on overall returns.
Meaningful U.S. Weight in an International Fund
Despite being an international ETF, a sizable portion is still invested in U.S. stocks, which may reduce the diversification benefit for investors already holding U.S. funds.
Moderate Expense Ratio
While not especially high, the fund’s fees are not the lowest available, so costs will slightly reduce long-term returns compared with the cheapest international ETFs.

AVDE vs. SPDR S&P 500 ETF (SPY)

AVDE Summary

AVDE, the Avantis International Equity ETF, invests in a wide mix of companies outside the U.S., aiming to capture the overall international stock market rather than track a single index. It holds firms from many countries and sectors, including well-known names like ASML Holding and Toyota Motor, giving investors broad global diversification in one fund. Someone might invest in AVDE to spread their money across many international companies and seek long-term growth beyond the U.S. market. A key risk is that international stocks can be volatile and can go up or down with global market and currency swings.
How much will it cost me?The Avantis International Equity ETF (AVDE) has an expense ratio of 0.23%, meaning you’ll pay $2.30 per year for every $1,000 invested. This cost is lower than average for actively managed funds because AVDE uses a blend of quantitative techniques and fundamental insights to manage its portfolio efficiently.
What would affect this ETF?The Avantis International Equity ETF (AVDE) could benefit from growth in developed markets outside the U.S., particularly if sectors like financials and industrials, which make up a significant portion of its holdings, experience strong performance due to favorable economic conditions or technological advancements. However, it may face challenges from global economic slowdowns, regulatory changes, or geopolitical tensions that impact key regions or companies like Shell, Roche, and Toyota Motor. Interest rate fluctuations and currency risks could also influence the ETF's returns, given its international exposure.

AVDE Top 10 Holdings

AVDE leans on a mix of global heavyweights, with Dutch chip-equipment maker ASML and mining giant BHP doing much of the heavy lifting as their shares keep rising. Financials are another key engine: HSBC and Allianz have been climbing, giving the fund a steady boost. On the flip side, Toyota and France’s Safran have been losing steam lately, acting as mild drags rather than full-on anchors. Overall, the ETF is broadly diversified across sectors and is firmly planted outside the U.S., with exposure spread across Europe and other developed markets.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding1.20%$185.52M$546.33B110.04%
81
Outperform
Roche Holding AG0.92%$141.57M$329.96B30.11%
73
Outperform
Shell0.90%$139.08M$248.05B37.23%
78
Outperform
HSBC Holdings0.80%$124.07M$309.74B60.93%
78
Outperform
Novartis0.62%$94.99M$269.97B32.66%
80
Outperform
BHP Group0.55%$84.11M$203.00B61.91%
73
Outperform
BP0.54%$83.30M$118.74B59.83%
68
Neutral
AstraZeneca0.54%$82.58M$302.77B38.76%
80
Outperform
Allianz0.53%$81.44M€147.73B9.12%
67
Neutral
Celestica0.53%$81.06M$45.11B325.00%
73
Outperform

AVDE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
87.71
Positive
100DMA
85.93
Positive
200DMA
81.30
Positive
Market Momentum
MACD
0.90
Negative
RSI
53.92
Neutral
STOCH
24.18
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVDE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 87.99, equal to the 50-day MA of 87.71, and equal to the 200-day MA of 81.30, indicating a bullish trend. The MACD of 0.90 indicates Negative momentum. The RSI at 53.92 is Neutral, neither overbought nor oversold. The STOCH value of 24.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVDE.

AVDE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$15.49B0.23%
65
Neutral
$19.15B0.27%
65
Neutral
$18.66B0.36%
60
Neutral
$15.79B0.18%
64
Neutral
$13.63B0.22%
63
Neutral
$2.05B0.54%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVDE
Avantis International Equity ETF
88.86
22.57
34.05%
DFIV
Dimensional International Value ETF
AVDV
Avantis International Small Cap Value ETF
DFAI
Dimensional International Core Equity Market ETF
DFIC
Dimensional International Core Equity 2 ETF
CGIE
Capital Group International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement